维普中文期刊产品整合服务
4篇 您的检索式:作者名="Perry Maxwell"
    题名 作者 年代 出处 被引量
1Tissue temperatures during ultrasound--assisted lipoplasty 显示文摘 Gingrass MK Perry LC Fisher J Maxwell GP 1998Plast Reconstr Surg1998,102,2:1
2FOXP3 + regulatory T ‐cell counts correlate with histological response in C rohn’s colitis treated with infliximab显示文摘Samuel Sloan Perry Maxwell Manuel Salto‐Tellez Maurice B. Loughrey 2014Pathol Int2014,,12:1
3Reduction of mitomycin C resistance in human bladder cancer T24 cells by knocking-down ras oncogene显示文摘Aim:Mitomycin C(MMC)is a commonly used as intravesical treatment for superficial bladder cancer.However,its role in combination with ras inhibition has not been investigated.The aim of this study was to explore the role of ras in MMC-induced apoptosis in T24 bladder cancer cells and to determine the efficacy of combination therapy in vitro.Methods:We measured the effects of various doses of MMC on apoptosis induction as well as on ras,ERK and Ki-67 protein expression by T24 cell line using immunocytochemistry,flow cytometry and Western blotting.We also tested the effect of siRNA on ras employed singly or in combination with MMC.Results:T24 cells expressed high level of ras protein.MMC treatment increased the level of ras and ERK protein expression after 24 h,and decreased these levels after 72 h.Ras siRNA(100 nmol/L)caused massive apoptosis associated with a marked decrease in ras expression in T24 cells.When combined with low doses of MMC,ras siRNA(50 nmol/L)sensitized T24 cells to apoptosis and decreased their expression of ras.The effect of combined therapy was higher than that of either compound used alone.Expression levels of ERK,a downstream target of ras,declined following combination therapy.Conclusion:Ras siRNA in combination with low dose MMC is a possible treatment strategy for patients with ras-positive bladder tumors.Osama Sharaf Eldin Abdel-Motaal Fouda Amany R.Youssef Peter Hamilton Perry Maxwell Kate E.Williamson 2018Cancer Drug Resistance2018,1,1:1
4Medication use and risk of falls显示文摘Neutel CI Perry S Maxwell C 2002Pharmacoepidemiol Drug Saf2002,11,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费